Genome-Wide Association Study of d-Amphetamine Response in Healthy Volunteers Identifies Putative Associations, Including Cadherin 13 (CDH13)

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Hart, Amy B ^a   Engelhardt, Barbara E ^a,b   Wardle, Margaret C ^a   Sokoloff, Greta ^a   Stephens, Matthew ^a   de Wit, Harriet ^a   Palmer, Abraham A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b THE UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; CADHERIN; CADHERIN 13; DEXAMPHETAMINE; PLACEBO; STEROID 5ALPHA REDUCTASE; STEROID 5ALPHA REDUCTASE ALPHA POLYPEPTIDE 1; UNCLASSIFIED DRUG; ELTANOLONE; H CADHERIN; H-CADHERIN;

ADULT; AFFECT; AMPHETAMINE DEPENDENCE; ARTICLE; CDH13 GENE; DRUG DEPENDENCE; DRUG RESPONSE; ENZYME ACTIVITY; FACTORIAL ANALYSIS; FEMALE; GENE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; HERITABILITY; HUMAN; HUMAN EXPERIMENT; INTRON; MALE; NORMAL HUMAN; PHARMACOGENOMICS; SINGLE NUCLEOTIDE POLYMORPHISM; SRD5A1 GENE; STEROIDOGENESIS; VOLUNTEER; ADOLESCENT; BIOLOGICAL MODEL; DOUBLE BLIND PROCEDURE; GENETICS; PHENOTYPE; RISK FACTOR;

ADOLESCENT; ADULT; CADHERINS; DEXTROAMPHETAMINE; DOUBLE-BLIND METHOD; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTRONS; MALE; MODELS, GENETIC; PHENOTYPE; PLACEBOS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANOLONE; RISK FACTORS;

EID: 84865457476     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042646     Document Type: Article

References (87)

1. Hart AB, de Wit H, Palmer A (2012) Genetic factors modulating the response to stimulant drugs in humans. In: Reif A, Cryan J, editors. Behavioral Neurogenetics, In: Current Topics in Behavioral Neurosciences: Behavioral Neurogenetics. Heidelberg, Germany: Springer.
2. Crabbe J, Jarvik L, Liston E, Jenden D, (1983) Behavioral responses to amphetamines in identical twins. Acta Genet Med Gemellol (Roma) 32: 139-149.
3. Nurnberger J, (1982) Behavioral, biochemical and neuroendocrine responses to amphetamine in normal twins and 'well-state' bipolar patients. Psychoneuroendocrinology 7: 163-176.
4. Chen X, Stacy A, Zheng H, Shan J, Spruijt-Metz D, et al. (2003) Sensations from initial exposure to nicotine predicting adolescent smoking in China: A potential measure of vulnerability to nicotine. Nicotine & Tobacco Research 5: 455-463.
5. DiFranza JR, Savageau JA, Fletcher K, Ockene JK, Rigotti NA, et al. (2004) Recollections and repercussions of the first inhaled cigarette. Addictive behaviors 29: 261-272.
6. Fergusson D, Horwood L, Lynskey M, Madden P, (2003) Early reactions to cannabis predict later dependence. Archives of General Psychiatry 60: 1033-1039.
7. King AC, De Wit H, McNamara PJ, Cao D, (2011) Rewarding, Stimulant, and Sedative Alcohol Responses and Relationship to Future Binge Drinking. Archives of general psychiatry 68: 389-399.
8. Le Strat Y, Ramoz N, Horwood J, Falissard B, Hassler C, et al. (2009) First positive reactions to cannabis constitute a priority risk factor for cannabis dependence. Addiction 104: 1710-1717.
9. Schuckit MA, (1994) Low level of response to alcohol as a predictor of future alcoholism. American Journal of Psychiatry 151: 184-189.
10. Lott D, Kim S, Cook E, de Wit H, (2005) Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology 30: 602-609.
11. Hamidovic A, Dlugos A, Palmer AA, de Wit H, (2010) Polymorphisms in Dopamine Transporter (SLC6A3) are Associated with Stimulant Effects of d-Amphetamine: An Exploratory Pharmacogenetic Study Using Healthy Volunteers. Behav Genet 40: 255-261.
12. Hamidovic A, Dlugos A, Skol A, Palmer AA, de Wit H, (2009) Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: An exploratory study with d-amphetamine in healthy participants. Experimental and Clinical Psychopharmacology 17: 374-383.
13. Lott D, Kim S, Cook E Jr, de Wit H, (2006) Serotonin transporter genotype and acute subjective response to amphetamine. American Journal on Addictions 15: 327-335.
14. Dlugos A, Freitag C, Hohoff C, McDonald J, Cook E, et al. (2007) Norepinephrine transporter gene variation modulates acute response to D-amphetamine. Biological Psychiatry 61: 1296-1305.
15. Dlugos AM, Hamidovic A, Hodgkinson CA, Goldman D, Palmer AA, et al. (2009) More Aroused, Less Fatigued: Fatty Acid Amide Hydrolase Gene Polymorphisms Influence Acute Response to Amphetamine. Neuropsychopharmacology 35: 613-622.
16. Mattay V, Goldberg T, Fera F, Hariri A, Tessitore A, et al. (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proceedings of the National Academy of Sciences of the United States of America 100: 6186.
17. Hamidovic A, Dlugos A, Palmer A, de Wit H, (2010) Catechol-O-methyltransferase val158met genotype modulates sustained attention in both the drug-free state and in response to amphetamine. Psychiatric Genetics 20: 85.
18. Dlugos AM, Hamidovic A, Palmer AA, de Wit H, (2009) Further evidence of association between amphetamine response and SLC6A2 gene variants. Psychopharmacology (Berl) 206: 501-511.
19. Flanagin B, Cook E Jr, de Wit H, (2006) An association study of the brain-derived neurotrophic factor Val66Met polymorphism and amphetamine response. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 141: 576-583.
20. Veenstra-VanderWeele J, Qaadir A, Palmer A, Cook E, de Wit H, (2005) Association between the casein kinase 1 epsilon gene region and subjective response to D-amphetamine. Neuropsychopharmacology 31: 1056-1063.
21. Kirisci L, Tarter R, Mezzich A, Vanyukov M, (2007) Developmental trajectory classes in substance use disorder etiology. Psychology of Addictive Behaviors 21: 287-296.
22. Goldman D, Ducci F, (2007) Deconstruction of vulnerability to complex diseases: enhanced effect sizes and power of intermediate phenotypes. TheScientificWorldJOURNAL 7: 124-130.
23. Hodgkinson CA, Enoch M-A, Srivastava V, Cummins-Oman JS, Ferrier C, et al. (2010) Genome-wide association identifies candidate genes that influence the human electroencephalogram. Proc Natl Acad Sci USA 107: 8695-8700.
24. Daly AK, (2010) Genome-wide association studies in pharmacogenomics. Nature Reviews Genetics 11: 241-246.
25. Huang RS, Duan S, Shukla SJ, Kistner EO, Clark TA, et al. (2007) Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach. American Journal of Human Genetics 81: 427-437.
26. Cooper GM, Johnson JA, Langaee TY, Feng H, Stanaway IB, et al. (2008) A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose. Blood 112: 1022.
27. Uher R, Perroud N, Ng MYM, Hauser J, Henigsberg N, et al. (2010) Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. American Journal of Psychiatry 167: 555.
28. Best T, Li D, Skol AD, Kirchhoff T, Jackson SA, et al. (2011) Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma. Nat Med 17: 941-943.
29. Tanaka Y, Kurosaki M, Nishida N, Sugiyama M, Matsuura K, et al. (2011) Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C. Human Molecular Genetics.
30. Weber F, Cepok S, Wolf C, Berthele A, Uhr M, et al. (2011) Single-nucleotide polymorphisms in HLA-and non-HLA genes associated with the development of antibodies to interferon-β therapy in multiple sclerosis patients. The Pharmacogenomics Journal.
31. Engelhardt BE, Stephens M, (2010) Analysis of Population Structure: A Unifying Framework and Novel Methods Based on Sparse Factor Analysis. PLoS Genet 6: e1001117.
32. West M, (2003) Bayesian factor regression models in the "large p, small n" paradigm. Bayesian statistics 7: 723-732.
33. Johanson C, Uhlenhuth E, (1980) Drug preference and mood in humans: diazepam. Psychopharmacology (Berl) 71: 269-273.
34. Foltin RW, Fischman MW, (1991) Assessment of abuse liability of stimulant drugs in humans: a methodological survey. Drug Alcohol Depend 28: 3-48.
35. Chait L, Fischman MW, Schuster CR, (1985) 'Hangover' effects the morning after marijuana smoking. Drug and Alcohol Dependence 15: 229-238.
36. Lynskey MT, Grant JD, Li L, Nelson EC, Bucholz KK, et al. (2007) Stimulant use and symptoms of abuse/dependence: epidemiology and associations with cannabis use-a twin study. Drug Alcohol Depend 86: 147-153.
37. Roweis S, (1998) EM algorithms for PCA and SPCA. Advances in neural information processing systems pp. 626-632.
38. Verbeek J, Vlassis N, Kröse B (2002) Procrustes analysis to coordinate mixtures of probabilistic principal component analyzers. IAS-UVA 2.
39. R Core Development Team (2009) R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
40. Stacklies W, Redestig H, Scholz M, Walther D, Selbig J, (2007) pcaMethods-a bioconductor package providing PCA methods for incomplete data. Bioinformatics 23: 1164-1167.
41. Korn JM, Kuruvilla FG, McCarroll SA, Wysoker A, Nemesh J, et al. (2008) Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nature genetics 40: 1253-1260.
42. Carvalho B, Bengtsson H, Speed TP, Irizarry RA, (2007) Exploration, normalization, and genotype calls of high-density oligonucleotide SNP array data. Biostatistics 8: 485.
43. Howie BN, Donnelly P, Marchini J, (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 5: e1000529.
44. Durbin RM, Altshuler DL, Abecasis GR, Bentley DR, Chakravarti A, et al. (2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073.
45. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851-861.
46. Patterson N, Price AL, Reich D, (2006) Population structure and eigenanalysis. PLoS Genet 2: e190.
47. Guan Y, Stephens M, (2008) Practical issues in imputation-based association mapping. PLoS Genetics 4: e1000279.
48. Marchini J, Howie B, Myers S, McVean G, Donnelly P, (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nature genetics 39: 906-913.
49. Servin B, Stephens M, (2007) Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS Genet 3: e114.
50. Takeuchi T, Misaki A, Liang SB, Tachibana A, Hayashi N, et al. (2000) Expression of T-cadherin (CDH13, H-Cadherin) in human brain and its characteristics as a negative growth regulator of epidermal growth factor in neuroblastoma cells. J Neurochem 74: 1489-1497.
51. Agís-Balboa RC, Pinna G, Zhubi A, Maloku E, Veldic M, et al. (2006) Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. Proc Natl Acad Sci USA 103: 14602-14607.
52. Uhl GR, Drgon T, Liu Q-R, Johnson C, Walther D, et al. (2008) Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Archives of General Psychiatry 65: 345-355.
53. Johnson C, Drgon T, Liu QR, Walther D, Edenberg H, et al. (2006) Pooled association genome scanning for alcohol dependence using 104,268 SNPs: validation and use to identify alcoholism vulnerability loci in unrelated individuals from the collaborative study on the genetics of alcoholism. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 141: 844-853.
54. Treutlein J, Cichon S, Ridinger M, Wodarz N, Soyka M, et al. (2009) Genome-wide association study of alcohol dependence. Archives of General Psychiatry 66: 773-784.
55. Drgon T, Montoya I, Johnson C, Liu Q-R, Walther D, et al. (2009) Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers. Mol Med 15: 21-27.
56. Uhl GR, Liu Q-R, Drgon T, Johnson C, Walther D, et al. (2007) Molecular genetics of nicotine dependence and abstinence: whole genome association using 520,000 SNPs. BMC Genet 8: 10.
57. Uhl GR, Drgon T, Johnson C, Walther D, David SP, et al. (2010) Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement. Pharmacogenomics 11: 357-367.
58. Liu QR, Drgon T, Johnson C, Walther D, Hess J, et al. (2006) Addiction molecular genetics: 639,401 SNP whole genome association identifies many "cell adhesion" genes. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 141: 918-925.
59. Johnson C, Drgon T, Walther D, Uhl GR, (2011) Genomic Regions Identified by Overlapping Clusters of Nominally-Positive SNPs from Genome-Wide Studies of Alcohol and Illegal Substance Dependence. PLoS One 6: e19210.
60. Edwards AC, Aliev F, Bierut LJ, Bucholz KK, Edenberg H, et al. (2012) Genome-wide association study of comorbid depressive syndrome and alcohol dependence. Psychiatric Genetics 22: 31-41.
61. Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, et al. (2010) Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nature genetics 42: 448-453.
62. Rivero O, Sich S, Popp S, Schmitt A, Franke B, et al. (2012) Impact of the ADHD-susceptibility gene CDH13 on development and function of brain networks. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology.
63. Lesch KP, Timmesfeld N, Renner TJ, Halperin R, Röser C, et al. (2008) Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. Journal of Neural Transmission 115: 1573-1585.
64. Lasky-Su J, Neale BM, Franke B, Anney RJL, Zhou K, et al. (2008) Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147: 1345-1354.
65. Neale BM, Medland S, Ripke S, Anney RJL, Asherson P, et al. (2010) Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 49: 906-920.
66. Zhou K, Dempfle A, Arcos-Burgos M, Bakker SC, Banaschewski T, et al. (2008) Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147: 1392-1398.
67. Arias-Vásquez A, Altink ME, Rommelse NNJ, Slaats-Willemse DIE, Buschgens CJM, et al. (2011) CDH13 is associated with working memory performance in Attention Deficit/Hyperactivity Disorder. Genes, brain, and behavior.
68. Terracciano A, Tanaka T, Sutin AR, Sanna S, Deiana B, et al. (2010) Genome-wide association scan of trait depression. Biological Psychiatry 68: 811-817.
69. Terracciano A, Sanna S, Uda M, Deiana B, Usala G, et al. (2010) Genome-wide association scan for five major dimensions of personality. Molecular psychiatry 15: 647.
70. Adkins D, Åberg K, McClay J, Bukszar J, Zhao Z, et al. (2010) Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. Molecular Psychiatry 16: 321-332.
71. de Moor MHM, Costa P, Terracciano A, Krueger R, de Geus E, et al. (2010) Meta-analysis of genome-wide association studies for personality. Molecular psychiatry.
72. Jee SH, Sull JW, Lee JE, Shin C, Park J, et al. (2010) Adiponectin concentrations: a genome-wide association study. The American Journal of Human Genetics 87: 545-552.
73. Wu Y, Li Y, Lange EM, Croteau-Chonka DC, Kuzawa CW, et al. (2010) Genome-wide association study for adiponectin levels in Filipino women identifies CDH13 and a novel uncommon haplotype at KNG1-ADIPOQ. Human Molecular Genetics 19: 4955-4964.
74. de Wit H, Richards JB, (2004) Dual determinants of drug use in humans: reward and impulsivity. Nebr Symp Motiv 50: 19-55.
75. Palmer A, de Wit H, (2012) Translational genetic approaches to substance use disorders: bridging the gap between mice and humans. Human Genetics 131: 931-939.
76. Thigpen A, Silver R, Guileyardo J, Casey ML, McConnell J, et al. (1993) Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. Journal of Clinical Investigation 92: 903.
77. Mellon SH, Griffin LD, Compagnone NA, (2001) Biosynthesis and action of neurosteroids. Brain research reviews 37: 3-12.
78. Brot MD, Akwa Y, Purdy RH, Koob GF, Britton KT, (1997) The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABAA receptors. European journal of pharmacology 325: 1-7.
79. Söderpalm AHV, Lindsey S, Purdy RH, Hauger R, de Wit H, (2004) Administration of progesterone produces mild sedative-like effects in men and women. Psychoneuroendocrinology 29: 339-354.
80. Childs E, Van Dam NT, de Wit H, (2010) Effects of acute progesterone administration upon responses to acute psychosocial stress in men. Experimental and clinical psychopharmacology 18: 78.
81. de Wit H, Schmitt L, Purdy R, Hauger R, (2001) Effects of acute progesterone administration in healthy postmenopausal women and normally-cycling women. Psychoneuroendocrinology 26: 697-710.
82. Zeller T, Wild P, Szymczak S, Rotival M, Schillert A, et al. (2010) Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PLoS One 5: e10693.
83. Gamazon ER, Badner JA, Cheng L, Zhang C, Zhang D, et al. (2012) Enrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar disorder susceptibility variants. Molecular psychiatry doi: 10.1038/mp.2011.174.
84. Ellis JA, Panagiotopoulos S, Akdeniz A, Jerums G, Harrap SB, (2005) Androgenic correlates of genetic variation in the gene encoding 5alpha-reductase type 1. Journal of Human Genetics 50: 534-537.
85. Milivojevic V, Kranzler HR, Gelernter J, Burian L, Covault J, (2011) Variation in genes encoding the neuroactive steroid synthetic enzymes 5α-reductase type 1 and 3α-reductase type 2 is associated with alcohol dependence. Alcohol Clin Exp Res 35: 946-952.
86. Yang B-Z, Han S, Kranzler HR, Farrer LA, Gelernter J, (2011) A Genomewide Linkage Scan of Cocaine Dependence and Major Depressive Episode in Two Populations. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology.
87. Alliey-Rodriguez N, Zhang D, Badner JA, Lahey BB, Zhang X, et al. (2011) Genome-wide association study of personality traits in bipolar patients. Psychiatric Genetics 21: 190-194.